These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15297275)

  • 1. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome.
    Tamm M; Aboyoun CL; Chhajed PN; Rainer S; Malouf MA; Glanville AR
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1120-3. PubMed ID: 15297275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
    J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E; Geltner C; Bucher B; Ulmer H; Höfer D; Hangler HB; Semsroth S; Margreiter R; Laufer G; Müller LC
    Transplantation; 2006 May; 81(10):1415-20. PubMed ID: 16732179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
    Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
    Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis.
    Hopkins PM; Aboyoun CL; Chhajed PN; Malouf MA; Plit ML; Rainer SP; Glanville AR
    Am J Respir Crit Care Med; 2004 Nov; 170(9):1022-6. PubMed ID: 15297270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.
    Johansson I; Mårtensson G; Nyström U; Nasic S; Andersson R
    BMC Infect Dis; 2013 Dec; 13():582. PubMed ID: 24325216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
    Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
    Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
    J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.